Showing 3971-3980 of 21451 results for "".
- Sex Differences in Mouse Brain GLP‑1 Mapping: Clinical Implicationshttps://reachmd.com/news/sex-differences-in-mouse-brain-glp1-mapping-clinical-implications/2485994/A recent report describes an RNAscope atlas of Glp1: a sex-specific
- ProstACT Part 1: TLX591-Tx Safety, Dosimetry, and Implications for Part 2https://reachmd.com/news/prostact-part-1-tlx591-tx-safety-dosimetry-and-implications-for-part-2/2485992/Telix Pharmaceuticals said ProstACT Global Part 1, the safety and dosimetry lead-in for
- BE BOLD: Bimekizumab Shows Superiority Over IL-23 Inhibitor in Psoriatic Arthritishttps://reachmd.com/news/be-bold-trial-bimekizumab-shows-superiority-over-il-23-inhibitor-in-psoriatic-arthritis/2486038/Bimekizumab achieved statistically significant superiority over risankizumab in reducing disease activity at Week 16 in adults with active psoriatic arthritis (PsA), according to topline results from the phase 3 BE BOLD head-to-head trial announced by UCB.
- In Relapsing MS, BTK Inhibitor Fenebrutinib Showed Reduced Relapse Rate vs Aubagiohttps://reachmd.com/news/in-relapsing-ms-btk-inhibitor-fenebrutinib-reduces-relapse-rate-vs-aubagio/2485955/Key Takeaways Results from the phase 3 FENhance 1 trial showed fenebrutinib reduced annualized relapse rate compared with Aubagio in people with relapsing multiple sclerosis. Combined results from FENhance 1 a
- Genotype‑Informed Nutrition in Obesity/Prediabeteshttps://reachmd.com/news/genotypeinformed-nutrition-in-obesityprediabetes/2485902/The systematic review Personalised Nutrition in Obesity and Prediabetes describes evidence for genotype-guided dietary response in adults with obesity or prediabetes as mixed across loci, endpoin
- Integrin αV–YAP–CTGF Signaling Links Congestion to Fibrosis and Cancerhttps://reachmd.com/news/integrin-vyapctgf-signaling-links-congestion-to-fibrosis-and-cancer/2485866/A Gastroenterology study used single-cell and spatial transcriptomic mapping in liver si
- Pooled ADORING Analysis: Tapinarof Linked to Early Sleep Improvements in Pediatric ADhttps://reachmd.com/news/pooled-adoring-analysis-tapinarof-linked-to-early-sleep-improvements-in-pediatric-ad/2485858/A pooled pediatric subanalysis from ADORING 1 and 2 was reported to show that once-daily
- ECG screening in 14–35-Year-Olds: Yield, Interventions, and Repeat Checkshttps://reachmd.com/news/ecg-screening-in-1435-year-olds-yield-interventions-and-repeat-checks/2485833/A large ECG screening cohort of 14–35-year-olds is described in the CRY ECG screening cohort, with the report highlighting how often potentially serious conditions were detected, what
- Bictegravir–Ienacapavir Single-Tablet Switchhttps://reachmd.com/news/bictegravirienacapavir-single-tablet-switch/2485843/A phase 3 randomized evaluated a once-daily bictegravir–lenacapavir single-tablet regimen as a swi
- REDEFINE 4: CagriSema 23% vs Tirzepatide 25.5% — Primary Non‑Inferiority Not Methttps://reachmd.com/news/redefine-4-cagrisema-23-vs-tirzepatide-255-primary-noninferiority-not-met/2485794/Novo Nordisk’s press release reports topline findings from REDEFINE 4, a he